RECURRENT MALIGNANT UTERINE CORPUS NEOPLASM
Clinical trials for RECURRENT MALIGNANT UTERINE CORPUS NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new RECURRENT MALIGNANT UTERINE CORPUS NEOPLASM trials appear
Sign up with your email to follow new studies for RECURRENT MALIGNANT UTERINE CORPUS NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced endometrial cancer: Three-Drug cocktails tested
Disease control OngoingThis study tested three different combinations of chemotherapy and targeted drugs in 349 people with advanced or recurrent endometrial cancer. The goal was to see which combination worked best to stop the cancer from growing or spreading. Participants received one of three treatm…
Matched conditions: RECURRENT MALIGNANT UTERINE CORPUS NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 03:24 UTC
-
New hope for recurrent ovarian and endometrial cancers: targeted drug shows promise
Disease control OngoingThis study tests a drug called tazemetostat in 62 people whose ovarian or endometrial cancer has returned after previous treatment. The drug works by blocking a protein that helps cancer cells grow. The main goal is to see if the drug can shrink tumors or stop them from growing f…
Matched conditions: RECURRENT MALIGNANT UTERINE CORPUS NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New drug duo targets Hard-to-Treat brain tumors
Disease control OngoingThis early-phase trial tests a new drug (MLN0128) combined with bevacizumab in people with recurrent glioblastoma (a brain cancer) or other advanced solid tumors that have stopped responding to standard treatments. The main goals are to find the safest dose and understand side ef…
Matched conditions: RECURRENT MALIGNANT UTERINE CORPUS NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:50 UTC
-
Gene test trial aims to outsmart advanced cancers
Knowledge-focused OngoingThis study tests whether analyzing the genes of a patient's tumor can help doctors choose a more effective treatment. Over 6,400 adults with advanced solid tumors, lymphomas, or multiple myeloma that have not responded to standard therapy are enrolled. The goal is to see if targe…
Matched conditions: RECURRENT MALIGNANT UTERINE CORPUS NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 17, 2026 03:11 UTC